跳至主要内容
临床试验/NCT01755663
NCT01755663Unknown4 期

Comparison of Efficacy and Safety of Ivabradine Versus Metoprolol for Controlling Heart Rate Prior to 640-Slice Computed Tomographic Angiography in Elective Patients

Col. Suthee Panichkul1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
Heart rate of patient before CT coronary

研究概览

简要总结

Ivabradine may be better than Metoprolol for controlling heart rate before Coronary CTA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elective patient on scheduled for 640 slices CT coronary at Phramonkutklao hospital
  • Resting heart rate > 70 BPM
  • age > 18 years and informed consent

排除标准

  • Heart rate > 100 BPM
  • BP <100/60 mmHg
  • recent congestive heart failure in 1 mo.
  • SA node, AV node disease and AF
  • on permanent pacemaker
  • CrCL < 15ml/min. , AST or ALT > 3x UNL
  • on HR reducing drug such as diltiazem, verapamil, digitalis
  • contraindication for ivabradine or metoprolol

研究组 & 干预措施

Ivabradine

Experimental

Patients will recieved ivabradine(5) 1 tab bid pc for 3 day and the day of CT, and recieve placebo of metoprolol

干预措施: Ivabradine and Metoprolol (Drug)

metoprolol

Active Comparator

Metoprolol (100) 1/2 tab bid pc for 3 day and the day of CT coronary , and placebo of ivabradine

干预措施: Ivabradine and Metoprolol (Drug)

结局指标

主要结局

Heart rate of patient before CT coronary

时间窗: 1 January 2013 to 31 december 2013

次要结局

  • safety and side effect of Metoprolol and Ivabradine(1 january 2013 to 31 december 2013)

研究者

发起方
Col. Suthee Panichkul
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Col. Suthee Panichkul

Col. Suthee Panichkul

Phramongkutklao College of Medicine and Hospital

研究点 (1)

Loading locations...

相似试验